Randomized Trial Comparing Laparoscopic Roux-en-y Gastric Bypass to Micro-laparoscopic Roux-en-y Gastric Bypass
Prospective Randomized Trial Comparing Laparoscopic Roux-en-y Gastric Bypass to Micro-laparoscopic Roux-en-y Gastric Bypass
1 other identifier
interventional
50
1 country
1
Brief Summary
Background Laparoscopy is the preferred surgical approach for a number of different diseases as it allows for diagnosis and treatment in the setting of a safe and feasible method offering enhanced cosmesis. The natural evolution of laparoscopy is micro-laparoscopy which utilizes smaller instruments and optics. Technological advancements have enabled miniaturization of the surgical equipment without compromising diagnostic or operative capabilities. Dr. Keith Zuccala is currently performing micro-laparoscopic gastric bypass with an identical safety profile as traditional laparoscopy (NSQIP data comparison between Dr. Laura Choi and Dr. Keith Zuccala). The current trend in laparoscopy is to minimize incisions and their size to decrease trauma to the abdominal wall. Study Design Both methods have never been compared in a prospective randomized trial to address the following questions.
- 1.Is there a difference in outcome?
- 2.Is there a decrease in postoperative pain?
- 3.Does it decrease time off from work?
- 4.Does micro-laparoscopy increase OR time?
- 5.What is the effect on cost of micro-laparoscopy? Patients will be randomized to one or the other method, disclosing that to the investigators best knowledge both methods are equally safe and that Dr. Zuccala has performed several hundred cases using both methods.
- 6.NSQIP data to assess outcome
- 7.Postoperative usage of pain medication while in the hospital
- 8.Time off from work
- 9.OR time
- 10.Direct cost of procedure as it relates to material used
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable obesity
Started Mar 2010
Longer than P75 for not_applicable obesity
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2010
CompletedFirst Submitted
Initial submission to the registry
August 9, 2010
CompletedFirst Posted
Study publicly available on registry
August 17, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2014
CompletedAugust 22, 2014
August 1, 2014
4.3 years
August 9, 2010
August 21, 2014
Conditions
Outcome Measures
Primary Outcomes (1)
Safety of micro-laparoscopic versus laparoscopic gastric bypass
2 years
Secondary Outcomes (4)
Postoperative pain
30 days
Time off from work
30 days
Operating Cost
The time of surgery is collected following patient discharge approximately 4 to 5 days
Time of Surgery
The time of surgery is collected following patient discharge approximately 4 to 5 days.
Study Arms (2)
Micro-laparoscopic bypass
ACTIVE COMPARATORLaparoscopic gastric bypass
ACTIVE COMPARATORInterventions
microlaparoscopic gastric bypass will be performed using standard of care procedure.
laparoscopic gastric bypass will be performed using standard of care procedure.
Eligibility Criteria
You may qualify if:
- A body mass index (BMI) ≥ 40 with or without co-morbid conditions\*
- A BMI ≥ 35 with co-morbid conditions\*
- Permanent lifestyle changes including exercise
- No significant, untreated psychiatric illnesses
- Age ≥ 18 years
- Sufficient ability and cognition to understand surgery, potential complications and subsequent associated changes
- Willingness to participate in treatment and long-term follow-up
- Proof of failed attempts at non-surgical weight reduction
- Acceptable medical/operative risks \* Co-morbid solutions include: hypertension, diabetes mellitus, cardiac disease, hypercholesterolemia/hyperlipidemia, sleep apnea, asthma, hypoventilation syndrome of obesity, degenerative joint disease, gastro-esophageal reflux disease, venous stasis ulcers, depression, menstrual irregularities/infertility, polycystic ovary syndrome, fungal skin infections.
You may not qualify if:
- The need to convert from laparoscopic roux-n-y to an open abdominal procedure.
- Patients with congestive heart failure or other serious illness which would prevent the patient from a successful surgery and recovery
- Women who are nursing or pregnant
- Patients who smoke
- Patient's insurance will not cover the cost of surgery.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Suzanne J. Roselead
- Ethicon Endo-Surgerycollaborator
Study Sites (1)
Danbury Hospital
Danbury, Connecticut, 06810, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Pierre Saldinger, M.D.
Danbury Hospital
- PRINCIPAL INVESTIGATOR
Keith Saldinger, M.D.
Danbury Hospital
- STUDY DIRECTOR
Suzanne J House, M.S., Ph.D.
Danbury Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Director, Office of Clinical Trials
Study Record Dates
First Submitted
August 9, 2010
First Posted
August 17, 2010
Study Start
March 1, 2010
Primary Completion
July 1, 2014
Study Completion
July 1, 2014
Last Updated
August 22, 2014
Record last verified: 2014-08